Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential dose-finding study of ropivacaine 0.2% background infusion for continuous interscalene block after rotator cuff repair
ChiCTR-TNC-11001351Phase 4Completed
- Sponsor
- Peking University Third Hospital
- Start
- Nov 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ropivacaine in rotator cuff tear, sponsored by Peking University Third Hospital. Primary endpoints: Numeric rating pain score, Minimum effective background infusion rate and 1 more. Started Nov 2010; status: completed.
02
Drugs
ropivacaine
03
Conditions
rotator cuff tear
Beyond the preview
Go deeper on ChiCTR-TNC-11001351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TNC-11001351.